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Abstract
Background: Massive duplication of effort occurs when researchers all over the world undertake extensive searches
for randomized controlled trials when preparing systematic reviews, when developing evidence-based guidelines
and when applying for research funding for eczema treatments. Such duplication wastes valuable resources.
Searching for randomized controlled trials of eczema is a laborious task involving scrutiny of thousands of
individual references from diverse electronic databases in order to obtain a few papers of interest. Clinicians and
patients who wish to find out more about a particular treatment are at risk of missing the relevant evidence if they
are not trained in electronic bibliographic searching. Systematic reviews cannot be relied upon to comprehensively
inform current optimal eczema treatments due to incomplete coverage and because many may be out of date.
An international, publically available and comprehensive resource which brings together all randomized controlled
trials on eczema treatment using a highly sensitive search has the potential to release more filtered knowledge
about patient care to those who need it most and to significantly shorten the duration and costs of many clinical
eczema research and guideline projects.
Description: The Global Resource of EczemA Trials brings together information on all randomized controlled trials
of eczema treatments published from the beginning of 2000 up to the end of 2010 and will be updated every
month.
We searched the Cochrane Central Register of Controlled Trials in The Cochrane Library and the Cochrane Skin
Group Specialised Register, MEDLINE, EMBASE, LILACS, AMED and CINHAL databases. We included 268 RCTs (24
th
March 2011) covering over 70 different treatment interventions.
The structure of the Global Resource of Eczema Trials allows the user as much, or as little, specificity when
retrieving information on trials as they wish, in an easy to use format. For each trial, the database gives the citation
for the published report and also provides enough information to enable a user to decide whether the trial is
worth further scrutiny.
Conclusions: The Global Resource of Eczema Trials has been created to facilitate knowledge mobilization into
healthcare and to reduce wastage of research time through unnecessary duplication. The collective time saved by
research groups around the world can now be used to make strides in optimising the treatment of eczema, in order to
further benefit people with eczema. The database can be accessed free of charge at http://www.greatdatabase.org.uk
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Eczema [1] is a complex, chronic and relapsing inflam-
matory skin disease affecting around 2 to 20% of chil-
dren worldwide [2,3]. The prevalence of eczema is
increasing [4], especially in children, although the rea-
sons for this increase are unclear. The constant itching,
sleep loss and visible stigmata of eczema can seriously
affect the quality of life of a child and family [5]. The
disease also can lead to high socioeconomic costs [6].
Eczema, as defined by the World Allergy Organisation,
encompasses both atopic and non-atopic eczema and is
commonly referred to as atopic eczema or atopic der-
matitis. Contact dermatitis and other forms of dermatitis
are considered to be separate conditions and are not
covered by the scope of this research [1].
Finding a needle in a haystack - searching and filtering
Eczema research is conducted all over the world: A pre-
requisite for much of this research such as applying for
funding, systematic reviews and developing clinical
guidelines, is to search for randomized controlled trials
(RCTs).
There are at least 48 (5 Cochrane and 43 non-
Cochrane) systematic reviews on treatments for eczema
covering a large number of eczema treatment areas
which have been mapped in our department on behalf
of NHS Evidence-skin disorders [7]. Whilst the coverage
of topic areas is encouraging, many interventions such
as intravenous immunoglobulin, liquorice extract, and
ketoconazole are currently not included in any form of
systematic review, and many existing systematic reviews
are out of date [8].
Searching is a laborious task involving wading through
hundreds and sometimes thousands of individual refer-
ences online followed by scrutiny of full paper copies of
studies and their associated citation lists in order to
obtain a few papers of interest [9]. Often the use of a
very sensitive search strategy is necessary in order to be
as inclusive as possible, as is the case when conducting
a Cochrane systematic review [10]. The more sensitive
the search, the more complete the research, however,
this adds to the number of references which need to be
manually filtered, thereby increasing the time taken to
complete a project.
A resource which brings together all RCTs on eczema
treatment using a highly sensitive, comprehensive search
has the potential to significantly shorten the length of
many eczema research projects. Just as some countries
like the UK host national reference collections of enti-
ties such as plant species in the National Collection of
Dahlias [11], our idea is to host a similar reference col-
lection of eczema RCTs that is freely accessible, com-
prehensive, easily searched and complete that can be
used for international eczema research, in the hope that
it will lead to improvement in patient care.
The Global Resource of EczemA Trials (GREAT)
database brings together information on all RCTs of
eczema treatments published from the beginning of
2000 for the first time. The database currently holds
records of all RCTs published and indexed up to the
end of 2010 and will be updated on an ongoing basis.
The database is restricted to RCTs from 2000 onwards
as information from trials published before this year can
be found in the Health Technology Assessment (HTA)
systematic review on treatments for atopic eczema [12],
a highly accessed HTA monograph at the time.
This systematic review included all randomized con-
trolled trials of eczema treatments involving people with
established eczema. The extracted information from the
trials was presented in concise sections summarising the
benefits and harms for each treatment, with comments
on the quality of reporting of the trials. Information was
also summarised in tables for many of the treatments
reviewed.
The search strategy for Global Resource of Eczema
Trials is very similar to the searches conducted for this
HTA review.
Construction and Content
To be included in the GREAT database, a trial has to
fulfil the following broad criteria:
1. The trial report must include a clear mention of
randomisation
2. The participants must have established eczema
either diagnosed by a clinician or using the Hanifin
and Rajka criteria [13] or the UK Working party cri-
teria [14], or criteria very close to these.
3. There must be prospective allocation of people
with eczema to two or more interventions
4. The trial must measure at least one efficacy
outcome
Search strategy
To ensure that as many RCTs as possible were identi-
fied, we searched the Cochrane Central Register of Con-
trolled Trials (CENTRAL) in The Cochrane Library and
the Cochrane Skin Group Specialised Register, which
includes handsearching of dermatology conference pro-
ceedings, as well as MEDLINE (Ovid), EMBASE (Ovid)
(Table 1), LILACS, AMED and CINAHL databases from
the beginning of 2000 to the end of 2010.
The searches for MEDLINE and EMBASE were based
o nt h eC o c h r a n eh i g h l ys e n s i t i v es e a r c hs t r a t e g yf o r
RCTs [10], combined with a list of known terms for
eczema, intended to be as comprehensive as possible.
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The GREAT database has been constructed with ease of
use as its primary objective. The structure of the data-
base allows the user as much, or as little, specificity as
they wish. The GREAT database website scores 94% for
accessibility using the LIDA instrument, a tool which
assesses accessibility by looking at page setup, access
restrictions, amount of outdated code and compatibility
with NHS directives [15]. The website is already being
accessed in the UK as well as around the world in coun-
tries such as Sudan, Germany, Ireland, United States,
Poland, France and Spain [16].
If a particular treatment area (such as non-pharmaco-
logical treatments) is of interest, the menus across the
top of every page offer a list of treatment categories
from which it is possible to see a list of all treatments in
that category. From the list of treatments, a specific
treatment of interest can be selected, which will give a
list of the trials looking at that treatment. Selecting a
trial will give access to the trial information (Figure 1).
If a particular trial is of interest and at least one piece
of information is known, such as the author or title, the
‘trials’ page or the ‘search’ page allows the trial details to
be accessed directly. The search facility also allows the
user to search for a term of interest, such as ‘SCORAD’
or ‘double blind’ and quickly have access to a list of
trials whose records contain the term (Figure 2).
All levels of specificity are catered for: a search for all
trials from a certain year is possible through buttons on
the trials page, as are an alphabetical journal search and
first author search from this page.
Trial information
For each trial, the database gives the citation for the pub-
l i s h e dr e p o r t .A sw e l la st h i si tp r o v i d e si n f o r m a t i o no n
the trial in a clear and simple format. There is basic infor-
mation about the interventions, study design and metho-
dology (such as use of blinding and intention-to-treat
methods), number of participants randomized, withdra-
wals, outcomes, authors’ conclusions, sponsorship, con-
flicts of interest and quality of reporting (Figure 3).
A further, deeper level of data on each trial in the
GREAT database has been extracted including the
results of efficacy outcomes with all associated numeri-
cal data. This opens up the possibility of our team colla-
borating with interested groups who need access to
properly extracted data on eczema treatments to speed
up the production of research such as systematic
reviews and clinical guidelines. Interested groups should
contact the authors to discuss this in more detail.
The information provided aims to allow users of the
GREAT database to quickly and easily decide if the trial
is of interest to them. The complete citation(s) for each
trial are given to facilitate obtaining the full paper for
further scrutiny.
Cochrane Central Register of Controlled Trials (Clinical
Trials)
T h eo n l yo t h e rd a t a b a s ew h i c hc o n t a i n sr e c o r d so f
RCTs of eczema (as well as RCTs on all other medical
subjects) and is updated regularly is Clinical Trials. The
Clinical Trials database gives details of RCTs and con-
trolled clinical trials (CCTs) on eczema treatment taken
from MEDLINE, EMBASE and other databases along
with the Cochrane Groups’ specialised registers, which
include citations found by handsearching. The Cochrane
Skin Group Specialised Register has been collecting full
paper copies of CCTs and RCTs for 12 years.
The information given on each trial in Clinical Trials
often includes the abstract and may allow the user to
retrieve the full paper. The Clinical Trials database gives
a very thorough list of published and unpublished
reports of trials and is useful for those interested in
C C T sa sw e l la sR C T s ,b u ti td o e sn o tg i v ea n y
extracted information. By comparison, the GREAT data-
base gives enough information to usually save having to
retrieve the full paper for every single eczema trial. Also,
if only interested in eczema, skills in database searching
Table 1 EMBASE search strategy
1. random$.mp.
2. factorial$.mp.
3. (crossover$ or cross-over$).mp.
4. placebo$.mp. or PLACEBO/
5. (doubl$ adj blind$).mp.
6. (singl$ adj blind$).mp.
7. (assign$ or allocat$).mp.
8. volunteer$.mp. or VOLUNTEER/
9. Crossover Procedure/
10. Double Blind Procedure/
11. Randomized Controlled Trial/
12. Single Blind Procedure/
1 3 .1o r2o r3o r4o r5o r6o r7o r8o r9o r1 0o r1 1o r1 2
14. exp Dermatitis, Atopic/
15. atopic dermatitis.mp.
16. atopic eczema.mp.
17. exp NEURODERMATITIS/
18. neurodermatitis.mp.
19. infantile eczema.mp.
20. childhood eczema.mp.
21. (besnier$ and prurigo).mp.
22. eczema.mp. or exp Eczema/
23. 21 or 17 or 20 or 15 or 14 or 22 or 18 or 16 or 19
24. 23 and 13
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Figure 2 The GREAT database search facility.
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fully comprehensive list of only eczema trials from the
Clinical Trials database.
The GREAT database provides eczema researchers
w i t hav e r ys p e c i f i ct o o lw h i c hc a nb eu s e da l o n g s i d e
resources such as the Clinical Trials database.
The future of the GREAT database
For those in need of instant access to a list of RCTs
published between 2000 and 2010 on eczema treatments
the GREAT database now meets this need, however,
RCTs before and after this time period may still require
some hours of perseverance to retrieve citations and
papers of interest.
For pre-2000 trials, help is at hand from the HTA sys-
tematic review on treatments for eczema [12]. This pro-
vides full citations with some relevant and useful
information. There is, however, still significant effort
involved in wading through this document for each trial,
with no facility to quickly search for your area or trial of
interest. One way to extend the usefulness of this
resource in the future will be to provide information for
RCTs before 2000 though the GREAT database.
The search used to identify the RCTs included in the
database currently runs to the end of 2010, however, the
GREAT database would quickly lose some of its useful-
ness if there were no subsequent searches added. One
of the authors of the database (HN) will be undertaking
regular update searches until the end of 2013, when the
current project ends. It is the aspiration of the UK Cen-
tre of Evidence-Based Dermatology to continue the
work of keeping the information in the database up to
date past this point and well into the future and to
encourage and facilitate other research groups around
the world to prepare and maintain similar international
trial collections for other important skin diseases such
as psoriasis, melanoma and vitiligo.
Evaluation of the database against the systematic
reviews included in the 2009 and 2010 annual evidence
updates produced by NHS evidence - skin disorders [7]
f o u n dt h a ta l lb u taf e wo ft h eR C T sl i s t e di nt h ec i t a -
tions were included in the GREAT database. Many
RCTs included in the GREAT database were not found
in either the included or excluded studies of the relevant
systematic reviews.
An advantage of the GREAT database is that it can
and will be updated, so all RCTs found can be quickly
added. To ensure that missed RCTs are found, users of
the database are encouraged to alert the authors to
RCTs not currently included in GREAT.
Figure 3 The GREAT database - Individual trial information.
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The Global Resource of Eczema Trials has been created
to speed up eczema research. The collective time saved
by research groups around the world can now be used
to make strides in optimising the treatment of eczema,
in order to further benefit people with eczema. This up
to date resource fills a gap which no other resource cov-
ers in such detail. The database will also result in health
gains as knowledge locked in obscure RCTs is liberated
freely to health care professionals working in clinic, or
indeed to patients who wish to investigate the evidence
for a particular treatment. The database will continue to
be expanded in order to secure its place as the number-
one resource of randomized controlled trials on eczema
treatment both now and in the future.
Availability and requirements
The database is freely available online at http://www.
greatdatabase.org.uk
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